Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Heavitree Brewery FY11 Profit Down - Quick Facts

Heavitree Brewery (HVT.L) announced the preliminary statement of results for the year ended 31 October 2011. Profit for the year attributable to equity holders of the parent decreased to GBP 843 thousand from GBP 857 thousand last year. Earnings per share declined to 16.4 pence from 16.7 pence in the prior year.

Revenue declined to GBP 7.35 million from GBP 7.39 million in the prior year.

The company stated that its Directors recommend a final dividend of 3.5p per Ordinary and 'A' Limited Voting Ordinary Share (2010 - 3.5p) making a total for the year of 7p, which is unchanged from last year. The dividend will be paid on 20 April 2012, subject to shareholder approval at the Annual General Meeting on 13 April 2012, to shareholders on the Register at 23 March 2012.

Click here to receive FREE breaking news email alerts for Heavitree Brewery and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Proctor and Gamble (PG) has sold two of its soap brands to European consumer products giant Unilever (UN). Cincinnati-based P&G says the sale includes the global Camay brand, the Zest brand outside of North America and its Talisman manufacturing plant in Mexico. The plant employs approximately... Dish Network is no longer carrying Fox News in yet another dispute for the television provider. Fox News, which changed the face of cable news with its ardent advocacy of conservative issues, went dark Sunday, replaced on Dish by The Blaze, Glen Beck's new right-leaning channel. Fox Business channel... Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.